Results 31 to 40 of about 8,460 (122)
Systematic review with meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels
Alimentary Pharmacology &Therapeutics, Volume 54, Issue 8, Page 999-1012, October 2021., 2021 Systematic review and meta‐analysis: effect of inflammatory bowel disease therapy on lipid levels Summary Background Increase in lipid levels associated with the treatment of inflammatory bowel disease (IBD) has previously been reported. However, it is unknown if this effect is similar for all IBD drug classes.
Jasmijn A. M. Sleutjes +10 more
wiley +1 more source
Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations
Revista de Gastroenterología de México (English Edition), 2020 So far, available evidence suggests that patients with inflammatory bowel disease (IBD) are not at greater risk for developing COVID-19 infection.
J.L. de León-Rendón +2 more
doaj +1 more source
Twenty‐five years of biologicals in IBD: What´s all the hype about?
Journal of Internal Medicine, Volume 290, Issue 4, Page 806-825, October 2021., 2021 Abstract Twenty‐five years ago the field was revolutionized by the introduction of infliximab as the first hybrid anti‐TNF‐antibody. Subsequently, other humanized anti‐TNFs were developed and marketed, followed by antibodies to new targets including integrins (vedolizumab) and interleukin 12/23 (ustekinumab). All these so‐called biologicals were shown
Klaus R. Herrlinger, Eduard F. Stange
wiley +1 more source
Clinical characteristics of ulcerative colitis in elderly patients
JGH Open, Volume 5, Issue 8, Page 849-854, August 2021., 2021 Abstract The incidence of ulcerative colitis (UC) in elderly patients is increasing. Elderly UC patients are likely to exhibit distinct features both at diagnosis and during follow‐up. Age‐related problems, including complications, immune dysfunction, and multidrug use, make the diagnosis and treatment of elderly UC more challenging.
Mingming Zhu, Zhihua Ran
wiley +1 more source
WARNING TO DELAY IN DIAGNOSING MICROSCOPIC COLITIS IN OLDER ADULTS. A SERIES OF CASES [PDF]
Arquivos de GastroenterologiaBackground: Microscopic colitis (MC) is a chronic inflammatory bowel disease causing non-bloody diarrhea, and several cases are undiagnosed as a hidden cause of chronic diarrhea.
Lorete Maria da Silva KOTZE +4 more
doaj +1 more source
Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants [PDF]
, 2023 Background: Premature birth is an important issue in developing and developed countries. The purpose of this study is to investigate the effect of budesonide and surfactant in the treatment of respiratory distress syndrome and the prevention of ...
Norouzi, Elahe +4 more
core +1 more source
Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates [PDF]
, 2023 Antibody-drug conjugates consist of potent small molecule payloads linked to a targeting antibody. Payloads must possess a viable functional group by which a linker for conjugation can be attached.
Axel, Hernandez, Jr. +12 more
core +2 more sources
The role of Budesonide-MMX in active ulcerative colitis.
, 2014 Traditional corticosteroids represent a well-established and effective treatment for active ulcerative colitis (UC). However, the severity of their systemic side effects, led in recent years to look for new steroid molecules that could reduce them ...
RIZZELLO, FERNANDO +6 more
core +1 more source
, 2023 Supplemental material, sj-docx-1-tag-10.1177_17562848231188549 for Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and meta-analysis by Brigida ...
Brigida Barberio (6638741) +8 more
core +1 more source
UEG Week 2023 Poster Presentations
, 2023 United European Gastroenterology Journal, Volume 11, Issue S8, Page 535-1498, October 2023.
wiley +1 more source